OpenURL Connection Search

Select item for more details and to access through your institution.

Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.
Published in:
2022
By:
- Nirogi, Ramakrishna;
- Jayarajan, Pradeep;
- Benade, Vijay;
- Shinde, Anil;
- Goyal, Vinod Kumar;
- Jetta, Satish;
- Ravula, Jyothsna;
- Abraham, Renny;
- Grandhi, Venkata Ramalingayya;
- Subramanian, Ramkumar;
- Pandey, Santosh Kumar;
- Badange, Rajesh Kumar;
- Mohammed, Abdul Rasheed;
- Jasti, Venkat;
- Ballard, Clive;
- Cummings, Jeffrey
Publication type:
journal article
Neuroprotective Potential of Methanolic Extract of Saraca asoca Bark against Doxorubicin-Induced Neurotoxicity.
Published in:
Pharmacognosy Magazine, 2019, v. 15, n. 61, p. 309, doi. 10.4103/pm.pm_79_18
By:
- Cheruku, Sri Pragnya;
- Chamallamudi, Mallikarjuna Rao;
- Ramalingayya, Grandhi Venkata;
- Biswas, Subhankar;
- Gourishetti, Karthik;
- Nandakumar, Krishnadas;
- Devkar, Raviraj;
- Mallik, Sanchari Basu;
- Nampoothiri, Madhavan;
- Kumar, Nitesh
Publication type:
Article
Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo.
Published in:
Pharmacognosy Magazine, 2018, v. 14, p. S197, doi. 10.4103/pm.pm_364_17
By:
- Ramalingayya, Grandhi Venkata;
- Nayak, Pawan G.;
- Shenoy, Rekha R.;
- Mallik, Sanchari Basu;
- Gourishetti, Karthik;
- Hussain, Shalam M.;
- Rao, Chamallamudi Mallikarjuna;
- Nandakumar, Krishnadas
Publication type:
Article
5‐HT1A Receptor Agonist, SUVN‐N9503012 for the Treatment of Dementia and Associated Neuropsychiatric Disorders.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074640
By:
- Abraham, Renny;
- Petlu, Surendra;
- Thentu, Jagadeesh Babu;
- Grandhi, Venkata Ramalingayya;
- Raya, Anji Reddy;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Subramanian, Ramkumar;
- Rasheed, Mohammed Abdul;
- Nirogi, Ramakrishna
Publication type:
Article
SUVN‐I6107: A True Positive Allosteric Modulator (PAM) at Muscarinic M1 Receptors for the Treatment of Cognitive Disorders.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074091
By:
- Palacharla, Veera Raghava Chowdary;
- Guduru, Naga Sai Soma Chandra Sekhar;
- Medapati, Rajesh Babu;
- Srirangavaram, Maheshwari;
- Grandhi, Venkata Ramalingayya;
- Ganuga, Narender;
- Badange, Rajesh Kumar;
- Nakka, Harish;
- Subramanian, Ramkumar;
- Nirogi, Ramakrishna
Publication type:
Article
SUVN‐I7016031: A Novel M1‐receptor Positive Allosteric Modulator (M1‐PAM) for the treatment of Parkinson's Disease Associated Dementia.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.062698
By:
- Grandhi, Venkata Ramalingayya;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Tadiparthi, Jayaprakash;
- Jayarajan, Pradeep;
- Shinde, Anil K;
- Badange, Rajesh Kumar;
- Nirogi, Ramakrishna
Publication type:
Article
SUVN‐I6107: Efficacy and safety assessments of a true muscarinic M1‐positive allosteric modulator for the treatment of dementia.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051652
By:
- Abraham, Renny;
- Subramanian, Ramkumar;
- Grandhi, Venkata Ramalingayya;
- Muddana, NageswaraRao;
- Kamuju, Venkatesh;
- Badange, Rajesh Kumar;
- Reballi, Veena;
- Nirogi, Ramakrishna
Publication type:
Article
Masupirdine (SUVN‐502): A pure 5‐HT6 receptor antagonist ameliorates aggression‐like behavior in animal models: Development of new models and analysis methods/behavioral models.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039312
By:
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Grandhi, Venkata Ramalingayya;
- Medapati, Rajesh Babu;
- Kamuju, Venkatesh;
- Gandipudi, Sudhakar;
- Reballi, Veena;
- Jayarajan, Pradeep;
- Nirogi, Ramakrishna
Publication type:
Article
SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039288
By:
- Abraham, Renny;
- Goura, Venkatesh;
- Grandhi, Venkata Ramalingayya;
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Muddana, Nageswara Rao;
- Palacharla, Veera Raghava Chowdary;
- Bhyrapuneni, Gopinadh;
- Bojja, Kumar;
- Mekala, Venkat Reddy;
- Srirangavaram, Maheswari;
- Badange, Rajesh Kumar;
- Reballi, Veena;
- Goyal, Vinod Kumar;
- Pandey, Santosh Kumar;
- Jayarajan, Pradeep;
- Nirogi, Ramakrishna
Publication type:
Article
P2‐083: SUVN‐502: A PURE 5‐HT6 RECEPTOR ANTAGONIST AMELIORATES SENILE DEMENTIA IN ANIMAL MODELS.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P604, doi. 10.1016/j.jalz.2019.06.2490
By:
- Grandhi, Venkata Ramalingayya;
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Talakanti, Hemasundar Reddy;
- Abraham, Renny;
- Jayarajan, Pradeep;
- Saraf, Sangram Keshari;
- Nirogi, Ramakrishna;
- Jasti, Venkat
Publication type:
Article
P2‐094: SUVN‐502: A PURE 5‐HT6 RECEPTOR ANTAGONIST ALLEVIATES POST‐MENOPAUSE ASSOCIATED DEMENTIA IN AGED MENOPAUSE WISTAR RATS.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P703, doi. 10.1016/j.jalz.2018.06.779
By:
- Venkata, Ramalingayya Grandhi;
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Talakanti, Hemasundar Reddy;
- Abraham, Renny;
- Jayarajan, Pradeep;
- Nirogi, Ramakrishna
Publication type:
Article
P2‐080: SUVN‐502: A PURE 5‐HT6 ANTAGONIST AMELIORATES MEMORY DEFICIT IN TWO DIFFERENTIALLY CHALLENGED SOCIAL RECOGNITION TASKS.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P698, doi. 10.1016/j.jalz.2018.06.765
By:
- Nirogi, Ramakrishna;
- Venkata, Ramalingayya Grandhi;
- Ganuga, Narender;
- Talakanti, Hemasundar Reddy;
- Jayarajan, Pradeep
Publication type:
Article
SUVN-502 (A PURE 5-HT6 ANTAGONIST): PROMISING THERAPEUTIC POTENTIAL FOR PMAD (POST-MENOPAUSE-ASSOCIATED DEMENTIA) AND SMAD (SURGICAL MENOPAUSE-ASSOCIATED DEMENTIA).
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P637, doi. 10.1016/j.jalz.2017.06.731
By:
- Venkata, Ramalingayya Grandhi;
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Jayarajan, Pradeep;
- Nirogi, Ramakrishna
Publication type:
Article
NOVEL OBJECT RECOGNITION TASK: A SENSITIVE AND RELEVANT ANIMAL MODEL SYSTEM FOR EVALUATING POSTMENOPAUSE-RELATED DEMENTIA.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P287, doi. 10.1016/j.jalz.2017.06.187
By:
- Venkata, Ramalingayya Grandhi;
- Fernandes, Joylee;
- Tadiparthi, Jayaprakash;
- Ganuga, Narender;
- Medapati, Rajesh Babu;
- Jayarajan, Pradeep;
- Nirogi, Ramakrishna
Publication type:
Article
Female rats induced with mammary cancer as a relevant animal model for doxorubicin-induced chemobrain in vivo.
Published in:
Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 9, p. 862, doi. 10.1111/1440-1681.12596
By:
- Ramalingayya, Grandhi Venkata;
- Nayak, Pawan G;
- Shenoy, Rekha R;
- Rao, Chamallamudi Mallikarjuna;
- Nandakumar, Krishnadas
Publication type:
Article
Assessment of female rats for studying episodic memory and its deficit associated with doxorubicin-induced chemobrain.
Published in:
Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 6, p. 644, doi. 10.1111/1440-1681.12568
By:
- Ramalingayya, Grandhi Venkata;
- Gourishetti, Karthik;
- Kishore, Anoop;
- Nandakumar, Krishnadas
Publication type:
Article
Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.
Published in:
Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 309, doi. 10.3390/biom13020309
By:
- Nirogi, Ramakrishna;
- Jayarajan, Pradeep;
- Shinde, Anil;
- Mohammed, Abdul Rasheed;
- Grandhi, Venkata Ramalingayya;
- Benade, Vijay;
- Goyal, Vinod Kumar;
- Abraham, Renny;
- Jasti, Venkat;
- Cummings, Jeffrey
Publication type:
Article
Protective Effects of Aqueous Extract of Solanum nigrum Linn. Leaves in Rat Models of Oral Mucositis.
Published in:
Scientific World Journal, 2014, p. 1, doi. 10.1155/2014/345939
By:
- Patel, Alkesh;
- Biswas, Subhankar;
- Shoja, Muhammed Haneefa;
- Ramalingayya, Grandhi Venkata;
- Nandakumar, K.
Publication type:
Article

Found: 18

Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.

Neuroprotective Potential of Methanolic Extract of Saraca asoca Bark against Doxorubicin-Induced Neurotoxicity.

Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo.

5‐HT1A Receptor Agonist, SUVN‐N9503012 for the Treatment of Dementia and Associated Neuropsychiatric Disorders.

SUVN‐I6107: A True Positive Allosteric Modulator (PAM) at Muscarinic M1 Receptors for the Treatment of Cognitive Disorders.

SUVN‐I7016031: A Novel M<sub>1</sub>‐receptor Positive Allosteric Modulator (M<sub>1</sub>‐PAM) for the treatment of Parkinson's Disease Associated Dementia.

SUVN‐I6107: Efficacy and safety assessments of a true muscarinic M1‐positive allosteric modulator for the treatment of dementia.

Masupirdine (SUVN‐502): A pure 5‐HT<sub>6</sub> receptor antagonist ameliorates aggression‐like behavior in animal models: Development of new models and analysis methods/behavioral models.

SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility.

P2‐083: SUVN‐502: A PURE 5‐HT<sub>6</sub> RECEPTOR ANTAGONIST AMELIORATES SENILE DEMENTIA IN ANIMAL MODELS.

P2‐094: SUVN‐502: A PURE 5‐HT<sub>6</sub> RECEPTOR ANTAGONIST ALLEVIATES POST‐MENOPAUSE ASSOCIATED DEMENTIA IN AGED MENOPAUSE WISTAR RATS.

P2‐080: SUVN‐502: A PURE 5‐HT<sub>6</sub> ANTAGONIST AMELIORATES MEMORY DEFICIT IN TWO DIFFERENTIALLY CHALLENGED SOCIAL RECOGNITION TASKS.

SUVN-502 (A PURE 5-HT6 ANTAGONIST): PROMISING THERAPEUTIC POTENTIAL FOR PMAD (POST-MENOPAUSE-ASSOCIATED DEMENTIA) AND SMAD (SURGICAL MENOPAUSE-ASSOCIATED DEMENTIA).

NOVEL OBJECT RECOGNITION TASK: A SENSITIVE AND RELEVANT ANIMAL MODEL SYSTEM FOR EVALUATING POSTMENOPAUSE-RELATED DEMENTIA.

Female rats induced with mammary cancer as a relevant animal model for doxorubicin-induced chemobrain in vivo.

Assessment of female rats for studying episodic memory and its deficit associated with doxorubicin-induced chemobrain.

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.

Protective Effects of Aqueous Extract of Solanum nigrum Linn. Leaves in Rat Models of Oral Mucositis.